CNTA
Price
$25.00
Change
-$0.48 (-1.88%)
Updated
Feb 4 closing price
Capitalization
3.7B
49 days until earnings call
Intraday BUY SELL Signals
DYN
Price
$18.23
Change
-$0.73 (-3.85%)
Updated
Feb 4 closing price
Capitalization
3B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTA vs DYN

Header iconCNTA vs DYN Comparison
Open Charts CNTA vs DYNBanner chart's image
Centessa Pharmaceuticals
Price$25.00
Change-$0.48 (-1.88%)
Volume$870.27K
Capitalization3.7B
Dyne Therapeutics
Price$18.23
Change-$0.73 (-3.85%)
Volume$1.89M
Capitalization3B
CNTA vs DYN Comparison Chart in %
CNTA
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTA vs. DYN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and DYN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CNTA: $25.00 vs. DYN: $18.23)
Brand notoriety: CNTA and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 62% vs. DYN: 72%
Market capitalization -- CNTA: $3.7B vs. DYN: $3B
CNTA [@Biotechnology] is valued at $3.7B. DYN’s [@Biotechnology] market capitalization is $3B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than CNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 3 TA indicator(s) are bullish while DYN’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 3 bullish, 6 bearish.
  • DYN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DYN is a better buy in the short-term than CNTA.

Price Growth

CNTA (@Biotechnology) experienced а -0.95% price change this week, while DYN (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 26, 2026.

DYN is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($3.7B) has a higher market cap than DYN($3B). CNTA YTD gains are higher at: -0.040 vs. DYN (-6.800). CNTA has higher annual earnings (EBITDA): -227.27M vs. DYN (-445.29M). DYN has more cash in the bank: 792M vs. CNTA (246M). CNTA (118M) and DYN (120M) have identical debt. CNTA has higher revenues than DYN: CNTA (15M) vs DYN (0).
CNTADYNCNTA / DYN
Capitalization3.7B3B123%
EBITDA-227.27M-445.29M51%
Gain YTD-0.040-6.8001%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash246M792M31%
Total Debt118M120M98%
TECHNICAL ANALYSIS
Technical Analysis
CNTADYN
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANMX174.673.33
+1.94%
Oakmark Institutional
HFYCX14.650.05
+0.34%
Hartford Schroders Intl Multi-Cp Val C
PUVCX44.650.06
+0.13%
Putnam International Small Cap C
WSCYX19.81-0.24
-1.20%
Nomura Small Cap Growth Y
ETIEX13.24-0.47
-3.43%
Eventide Exponential Technologies I

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with NUVL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-1.88%
NUVL - CNTA
46%
Loosely correlated
-2.03%
VRDN - CNTA
44%
Loosely correlated
-4.80%
CLDX - CNTA
44%
Loosely correlated
-3.58%
ROIV - CNTA
43%
Loosely correlated
-1.46%
DYN - CNTA
41%
Loosely correlated
-3.85%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-3.85%
RNA - DYN
63%
Loosely correlated
-0.29%
IDYA - DYN
57%
Loosely correlated
-2.78%
APGE - DYN
55%
Loosely correlated
-5.82%
CRNX - DYN
54%
Loosely correlated
-5.06%
XNCR - DYN
53%
Loosely correlated
-3.84%
More